Literature DB >> 3001058

Human placental cytoplasmic 5'-nucleotidase. Kinetic properties and inhibition.

V Madrid-Marina, I H Fox.   

Abstract

The kinetic properties of highly purified human placental cytoplasmic 5'-nucleotidase were investigated. Initial velocity studies gave Michaelis constants for AMP, IMP, and CMP of 18, 30, and 2.2 microM, respectively. The enzyme shows the following relative Vmax values: CMP greater than UMP greater than dUMP greater than GMP greater than AMP greater than dCMP greater than IMP. The activity was magnesium-dependent, and this cation binds sequentially with a Km of 14 microM for AMP and an apparent Km of 6 mM for magnesium. A large variety of purine, pyrimidine, and pyridine compounds exert an inhibitory effect on enzyme activity. IMP, GMP, and NADH produce almost 100% inhibition at 1.0 mM. Nucleoside di- and triphosphates are potent inhibitors. ATP and ADP are competitive inhibitors with respect to AMP and IMP as substrates with Ki values of 100 and 15 microM, respectively. Inorganic phosphate is a noncompetitive inhibitor with Ki values of 19 and 43 mM. Nucleosides and other compounds studied produce only a modest decrease of enzyme activity at 1 mM. Our findings suggest that the enzyme is regulated under physiological conditions by the concentrations of magnesium, nucleoside 5'-monophosphates, and nucleoside di- and triphosphates. The nucleotide pool concentration regulates the enzyme possibly by a mechanism of heterogeneous metabolic pool inhibition. These properties of human placental cytoplasmic 5'-nucleotidase may be related to the control of nucleotide degradation in vivo.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3001058

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Developmental disorder associated with increased cellular nucleotidase activity.

Authors:  T Page; A Yu; J Fontanesi; W L Nyhan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 2.  5'-Nucleotidase: molecular structure and functional aspects.

Authors:  H Zimmermann
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

3.  Nucleotide ectoenzyme activities of human and Chinese hamster fibroblasts in tissue culture.

Authors:  J M Boyle; Y Hey; M Fox
Journal:  Biochem Genet       Date:  1989-12       Impact factor: 1.890

4.  Assignment of ecto-5'-nucleotidase to human chromosome 6.

Authors:  J M Boyle; Y Hey; A Guerts van Kessel; M Fox
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

5.  5'-Nucleotidases in rat heart. Evidence for the occurrence of two soluble enzymes with different substrate specificities.

Authors:  V L Truong; A R Collinson; J M Lowenstein
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

6.  Reconstitution of 5'-nucleotidase of bull seminal plasma in spin-labeled liposomes.

Authors:  C Fini; V D Thuong; M Aliante; A Floridi; S Cannistraro
Journal:  J Membr Biol       Date:  1994-10       Impact factor: 1.843

7.  The soluble 'low-Km' 5'-nucleotidase of rat kidney represents solubilized ecto-5'-nucleotidase.

Authors:  G Piec; M Le Hir
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

8.  Partial purification and properties of an AMP-specific soluble 5'-nucleotidase from pigeon heart.

Authors:  A C Skladanowski; A C Newby
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

9.  Expression patterns of AMP-deaminase and cytosolic 5'-nucleotidase genes in human term placenta.

Authors:  Anna Roszkowska; Jerzy Klimek; Krystian Kaletha
Journal:  Mol Cell Biochem       Date:  2007-12-30       Impact factor: 3.396

10.  NMDA receptor-mediated extracellular adenosine accumulation is blocked by phosphatase 1/2A inhibitors.

Authors:  Yin Lu; Paul A Rosenberg
Journal:  Brain Res       Date:  2007-05-04       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.